Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review.

[1]  B. Horta,et al.  The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. , 2002, American journal of ophthalmology.

[2]  G. Holland,et al.  An update on current practices in the management of ocular toxoplasmosis. , 2002, American journal of ophthalmology.

[3]  R. Gilbert,et al.  Antibiotics versus control for toxoplasma retinochoroiditis. , 2002, The Cochrane database of systematic reviews.

[4]  R. Nussenblatt,et al.  A follow-up study of Toxoplasma gondii infection in southern Brazil. , 2001, American journal of ophthalmology.

[5]  D. Podzamczer,et al.  Thrice-Weekly Sulfadiazine-Pyrimethamine for Maintenance Therapy of Toxoplasmic Encephalitis in HIV-Infected Patients , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[6]  M. Stanford,et al.  Is ocular toxoplasmosis caused by prenatal or postnatal infection? , 2000, The British journal of ophthalmology.

[7]  M. Stanford,et al.  Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications , 1999, Epidemiology and Infection.

[8]  M. Sendtner,et al.  Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. , 1999, Experimental parasitology.

[9]  R. Gilbert,et al.  Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling , 1999, The Lancet.

[10]  B. No̸rgaard-Pedersen,et al.  Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment , 1999, The Lancet.

[11]  A. Rothova,et al.  Azithromycin for ocular toxoplasmosis , 1998, The British journal of ophthalmology.

[12]  S. Lightman,et al.  Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease. , 1998, Investigative ophthalmology & visual science.

[13]  J. Isaac-Renton,et al.  Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. , 1998, Ophthalmology.

[14]  D. Lindsay,et al.  Structures of Toxoplasma gondiiTachyzoites, Bradyzoites, and Sporozoites and Biology and Development of Tissue Cysts , 1998, Clinical Microbiology Reviews.

[15]  G. Guyatt,et al.  Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[16]  J. Pepose,et al.  Ocular Infection and Immunity , 1996 .

[17]  D. Podzamczer,et al.  Intermittent Trimethoprim-Sulfamethoxazole Compared with Dapsone-Pyrimethamine for the Simultaneous Primary Prophylaxis of Pneumocystis Pneumonia and Toxoplasmosis in Patients Infected with HIV , 1995, Annals of Internal Medicine.

[18]  P. Piguet,et al.  Evaluation of the efficacy of prolonged administration of azithromycin in a murine model of chronic toxoplasmosis. , 1994, The Journal of antimicrobial chemotherapy.

[19]  R. Lynfield,et al.  Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. , 1994, The New England journal of medicine.

[20]  A Rothova,et al.  Ocular involvement in toxoplasmosis. , 1993, The British journal of ophthalmology.

[21]  P T de Jong,et al.  Therapy of ocular toxoplasmosis. , 1993, International ophthalmology.

[22]  J. Remington,et al.  Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. , 1991, The Journal of infectious diseases.

[23]  D. Jabs,et al.  Current practices in the management of ocular toxoplasmosis. , 1991, American journal of ophthalmology.

[24]  J. Koppe,et al.  RESULTS OF 20-YEAR FOLLOW-UP OF CONGENITAL TOXOPLASMOSIS , 1986, The Lancet.

[25]  J. Klein,et al.  Infectious Diseases of the Fetus and Newborn Infant , 1983 .

[26]  R. Humphrey,et al.  PROTEINURIA ASSOCIATED WITH DIETHYLCARBAMAZINE TREATMENT OF ONCHOCERCIASIS , 1980, The Lancet.

[27]  J. Chodos,et al.  The treatment of ocular toxoplasmosis with spiramycin. , 1961, Archives of ophthalmology.

[28]  E. Perkins,et al.  Treatment of Uveitis with Pyrimethamine (Daraprim) * , 1956, The British journal of ophthalmology.

[29]  T. Wreghitt,et al.  Toxoplasmosis: A comprehensive clinical guide , 2001 .

[30]  P. A. Pearson,et al.  Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. , 1999, Ophthalmology.

[31]  D. Minckler.  Acknowledging the importance of study design in the organization and quality of manuscripts. , 1999, Ophthalmology.

[32]  H. Bouguila,et al.  [Value of clindamycin in the treatment of ocular toxoplasmosis]. , 1997, Journal francais d'ophtalmologie.

[33]  R. Salamon,et al.  Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group. , 1996, The Journal of infectious diseases.

[34]  G. Theodossiadis,et al.  A comparative study concerning the treatment of active toxoplasmic retinochoroiditis with argon laser and medication (follow-up 2-9 years). , 1989, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[35]  J. Colin,et al.  Choriorétinites présumées toxoplasmiques: étude comparative des traitements par pyriméthamine et sulfadiazine ou clindamycine , 1989 .

[36]  T. E. Acers.  TOXOPLASMIC RETINOCHOROIDITIS: A DOUBLE BLIND THERAPEUTIC STUDY. , 1964, Archives of ophthalmology.